Harmony Biosciences HRMY is set to give its latest quarterly earnings report on Tuesday, 2024-10-29. Here's what investors need to know before the announcement.
Analysts estimate that Harmony Biosciences will report an earnings per share (EPS) of $0.66.
Harmony Biosciences bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings Track Record
The company's EPS beat by $1.11 in the last quarter, leading to a 2.19% increase in the share price on the following day.
Here's a look at Harmony Biosciences's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.06 | 0.62 | 0.48 | 0.65 |
| EPS Actual | 1.05 | 0.88 | 0.73 | 0.97 |
| Price Change % | 2.0% | -2.0% | 3.0% | 4.0% |
Performance of Harmony Biosciences Shares
Shares of Harmony Biosciences were trading at $34.5 as of October 25. Over the last 52-week period, shares are up 51.32%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Harmony Biosciences visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
